Jul 16, 2026 07:32AM
Jul 16, 2026 07:30AM
Jun 22, 2026 07:02AM
Jun 22, 2026 07:00AM
Jun 8, 2026 08:11AM
Jun 8, 2026 08:10AM
Jun 2, 2026 07:31AM Galmed and Tissue Dynamics identify cardiac fibrosis pathway
Jun 2, 2026 07:30AM
May 14, 2026 07:31AM
May 14, 2026 07:30AM
May 6, 2026 07:32AM
May 6, 2026 07:30AM
Apr 14, 2026 07:32AM
Apr 14, 2026 07:30AM Galmed Announces a Collaboration Agreement with Tel Aviv University to Evaluate its SCD1 inhibitor, Aramchol, as a Targeted Therapy for Metastatic Brain Cancers
Apr 9, 2026 07:30AM
Mar 31, 2026 04:15PM
Jan 30, 2026 04:15PM
Jan 30, 2026 04:15PM
Dec 8, 2025 08:32AM
Dec 8, 2025 08:30AM
Dec 4, 2025 08:32AM Galmed receives South Korea patent for Aramchol-Rezdiffra combination
Dec 4, 2025 08:30AM
Dec 1, 2025 08:30AM
Dec 1, 2025 08:30AM
Nov 26, 2025 08:30AM
Nov 18, 2025 08:30AM
Nov 17, 2025 08:31AM
Nov 17, 2025 08:30AM Galmed Announces Top-line Results in Oncology MoA Studies: A 3-drug combination of Aramchol, Stivarga® and Metformin Significantly Enhanced GI Tumor Cells, Killing In-vivo and In-vitro
Aug 28, 2025 08:00AM
Aug 25, 2025 07:31AM
Aug 25, 2025 07:30AM
May 27, 2025 08:00AM
May 22, 2025 08:00AM
May 13, 2025 08:00AM
May 6, 2025 07:30AM Galmed Announces First Time Results in Oncology Studies: Aramchol Significantly Enhances Bayer's Regorafenib Effect in GI Cancer Models
Apr 28, 2025 08:00AM
Apr 17, 2025 08:30AM
Apr 15, 2025 08:32AM
Apr 15, 2025 08:30AM
Apr 10, 2025 08:00AM
Apr 2, 2025 04:10PM
Sep 25, 2024 08:01AM Galmed Pharma (GLMD) reports Results from Aramchol Phase 3 Open Label part
Sep 25, 2024 08:00AM
Sep 20, 2024 09:00AM
Sep 19, 2024 07:06AM
Sep 19, 2024 07:00AM
Apr 4, 2024 05:06PM
Mar 15, 2024 09:01AM
Mar 15, 2024 09:00AM Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis
Nov 20, 2023 04:34PM

325,893 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All